Global Endoscopes Market Research Report
- Report Code: EN 1000
- Publish Date: Upcoming
The global endoscopes market, mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures, was valued at $11.9 billion in 2013, and expected to be $16.4 billion by 2018. It is expected to grow at a CAGR of 6.6%.
The report ‘Endoscopes Market forecast, 2008-2018’ analyzes the market of devices by segments such as rigid endoscopes, flexible endoscopes, surgical endoscopes, and capsule endoscopes. With a market value of $5 billion and $3.1 billion, the surgical endoscopes and flexible endoscopes segments have been contributing 41.7% and 26% respectively in terms of the total global endoscopes market. All of these segments experienced a positive growth with an increased awareness of patients and physicians towards the usage and reception of new endoscopy technologies due to the numerous advantages offered by these devices.
In the past decade, the demand for endoscopes has increased significantly, largely because of patients’ preference for minimally invasive surgeries. Endoscopic procedures are low-risk procedures and are easily covered by health insurance. A pivotal factor that propels the growth of the endoscopes market is the rapid rise in the number of elderly people who are prone to orthopedic, gastrointestinal, and ophthalmic, diseases as well as cancer. As per the World Health Organization (WHO), between 2000 and 2050, the proportion of the world's population that is aged 60 years will double from about 11% to 22%. This aging population is the main end-user of knee-hip implants, bariatric surgeries, gastrointestinal endoscopy, and colonoscopy procedures. With the growing number of elderly people, age-related ailments are also expected to rise sharply, thus propelling the demand and consumption of Endoscopes concomitantly.
The number of people in the world who are obese or overweight has reached 2.1 billion, from 875 million in 1980. Furthermore, approximately 7 million people in the United States have some symptoms of Gastroesophageal Reflux Disorder (GERD). Primary or secondary GERD diagnosis has increased from a total of 995,402 individuals diagnosed in 1998 to 3,141,965 in 2005. 4.2% of all people hospitalized with GERD in 2005 also had an esophageal disorder. In the United States, 1,150 deaths in 2004 were directly related to a primary diagnosis of GERD.
North America accounted for the highest share of the global endoscopes market followed by Europe, and Asia. North America and Europe both are likely to witness a demand for endoscopes as a result of technological advancements as well as improved reimbursement status in both the geographies. Rapidly aging population, increased obesity rates, and growing incidence of associated disease are some of the major factors driving the European endoscopes Market.
Ageing, chronically ill population, increasing affluence, increasing number of private sector hospitals, advancements in endoscopic technology, and expansion to rural healthcare facilities are also going to play a pivotal role in boosting the demand for endoscopy in the Asian region. China and India will be the focal point for growth of endoscopes market in the Asian market.
The endoscopy product market in the rest of the world is expected to grow at a faster pace due to improved reimbursement coverage, increasing government healthcare spending, as well as increasing awareness levels of patients regarding minimally invasive surgeries.
The report also provides an extensive competitive landscaping of companies operating in this market. The key players in this segment are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, Hoya Corporation, and Fujifilm Holdings Corporation.
Segment and country specific company shares, news & deals, mergers and acquisitions, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment wise and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country specific prevalence of cancer, gastrointestinal tract disorders, gastroesophageal reflux disorder (GERD), gynecological disorders.
- Country specific patient pool of cancer, gastrointestinal tract disorders, gastroesophageal reflux disorder (GERD), gynecological disorders.
- Disease progression (pattern analysis)
Procedure Volume Data
- Different types of endoscopy procedures performed annually in each country tracked till sub- segment level
- Number of abdominal, gastro intestinal, interior of joints, gynecology, bronchology, and large and small intestinal procedures performed in each country
Surgeons/Physicians Perception Matrix
- Fast turn-around analysis of surgeons’ response to market events and trends
- Surgeons’ opinion about products from different companies
- Surgeons’ qualitative inputs on epidemiology date
Pricing Trends
- Cost analysis of endoscopy devices in various countries
- Abdominal, gastro intestinal, interior of joints, gynecology, bronchology, and large & small intestinal procedural investment in major countries
Competitive Intelligence
- The company share analysis of Endoscopy devices for the top players of the market in the region.
- The crucial developments and strategies of companies inculcating in their portfolio for Endoscopy Devices.
Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Alternative Products: Impact analysis
MMM’s healthcare decision making Quadrant is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and cancer centers, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure).
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Applications
4.1 Laparoscopy
4.2 Arthroscopy
4.3 GI Endoscopy
4.4 Gynecological Endoscopy
4.5 Urology Endoscopy
4.6 Bronchoscopy
4.7 Mediastinoscopy
4.8 Otoscopy
4.9 Laryngoscopy
4.10 Other Endoscopy
5 By Types
5.1 Rigid Endoscopes
5.2 Flexible Endoscopes
5.3 Surgical Endoscopes
5.4 Capsule Endoscopes
6 By Services
6.1 Endoscopy Services
7 By Geographies
7.1 North America
7.2 Europe
7.3 Asia-Pacific
7.4 Rest of World
8 By Companies
8.1 Stryker Corporation
8.2 Ethicon Endo-Surgery, Inc
8.3 Olympus
8.4 Covidien Plc
8.5 Arthrex, Inc.
8.6 Smiths Group
8.7 HOYA CORPORATION
8.8 Boston Scientific
8.9 Aesculap, Inc
8.10 Richard Wolf GmbH
8.11 Invendo Medical GmbH
8.12 Karl Storz
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Laparoscopes Laparoscopes and Arthroscopes, Urology Endoscopes, |
Upcoming |
|
|
Arthroscopes Arthroscopes and Laparoscopes, Urology Endoscopes, |
Upcoming |
|
|
Urology Endoscopes Urology Endoscopes and Laparoscopes, Arthroscopes, |
Upcoming |
|
|
Cystoscopes Cystoscopes and Laparoscopes, Arthroscopes, |
Upcoming |
|
|
Gynecology Endoscopes Gynecology Endoscopes and Laparoscopes, Arthroscopes, |
Upcoming |
|
|
Neuroendoscopes Neuroendoscopes and Laparoscopes, Arthroscopes, |
Upcoming |
|
|
Colonoscopes Colonoscopes and Upper GI Endoscopes, Bronchoscopes, |
Upcoming |
|
|
Upper GI Endoscopes Upper GI Endoscopes and Colonoscopes, Bronchoscopes, |
Upcoming |
|
|
Bronchoscopes Bronchoscopes and Colonoscopes, Upper GI Endoscopes, |
Upcoming |
|
|
Sigmoidoscopes Sigmoidoscopes and Colonoscopes, Upper GI Endoscopes, |
Upcoming |
|
|
Laryngoscopes Laryngoscopes and Colonoscopes, Upper GI Endoscopes, |
Upcoming |
|
|
Global Rigid Endoscopes Market The Global Rigid Endoscopes Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $2.5 billion in 2013 and expected to be $3.4 billion by 2018, growing at a CAGR of 6.3%. The Rigid Endoscopes Market analyzes the market segments such as Laparoscope, Arthroscope, Cystoscope, Urology Endoscope, Gynecology Endoscope, Neuroendoscope, Other Rigid Endoscopes. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming |
|
|
Global Flexible Endoscopes Market The Global Flexible Endoscopes Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $3.1 billion in 2013 and expected to be $4.6 billion by 2018, growing at a CAGR of 8.2%. The Flexible Endoscopes Market analyzes the market segments such as Colonoscope, Bronchoscope, Upper GI Endoscope, Laryngoscope, Pharyngoscope, Deudonoscope, NasoPharyngoscope, Rhinoscope, Other Flexible Endoscopes. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming |
|
|
North American Endoscopes Market The North American endoscope market was valued at $4.9 billion in 2013 and is expected to reach $6.8 billion by 2018, growing at a CAGR of 6.8% during the forecast period. The key players in this market are Stryker Corporation, Ethicon Endo-Surgery, Inc., Olympus Corporation, Covidien plc, Arthrex, Inc., Smiths Group plc, Aesculap, Inc., ConMed Corporation, Richard Wolf GmbH, Hoya Corporation, and Fujifilm Holdings Corporation. The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have also been covered in the report. |
Upcoming |
|
|
European Endoscopes Market The European endoscope market was valued at $3.2 billion in 2013 and is expected to reach $4.2 billion by 2018, growing at a CAGR of 5.7% during the forecast period. The key players in this market are Stryker Corporation, Ethicon Endo-Surgery, Inc., Olympus Corporation, Covidien plc, Arthrex, Inc., Smiths Group plc, Aesculap, Inc., ConMed Corporation, Richard Wolf GmbH, Hoya Corporation, and Fujifilm Holdings Corporation. The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have also been covered in the report. |
Upcoming |
|
|
Asian Endoscopes Market The Asian endoscope market was valued at $2.9 billion in 2013 and is expected to reach $4.2 billion by 2018, growing at a CAGR of 7.6% during the forecast period. The key players in this market are Stryker Corporation, Ethicon Endo-Surgery, Inc., Olympus Corporation, Covidien plc, Arthrex, Inc., Smiths Group plc, Aesculap, Inc., ConMed Corporation, Richard Wolf GmbH, Hoya Corporation, and Fujifilm Holdings Corporation. The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have also been covered in the report. |
Upcoming |
|
|
North American Rigid Endoscopes Market The North American Rigid Endoscopes Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $1.03billion in 2013 and expected to be $1.41 billion by 2018, growing at a CAGR of 6.5%. The Endoscopes Market analyzes the market segments such as Laparoscope, Arthroscope, Cystoscope, Urology Endoscope, Gynecology Endoscope, Neuroendoscope, Other Rigid Endoscopes. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming |
|
|
European Rigid Endoscopes Market The European Rigid Endoscopes Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $0.66 billion in 2013 and expected to be $0.86 billion by 2018, growing at a CAGR of 5.4%. The Endoscopes Market analyzes the market segments such as Laparoscope, Arthroscope, Cystoscope, Urology Endoscope, Gynecology Endoscope, Neuroendoscope, Other Rigid Endoscopes. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming |
|
|
Asian Rigid Endoscopes Market The Asian Rigid Endoscopes Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $0.61 billion in 2013 and expected to be $0.86 billion by 2018, growing at a CAGR of 7.2%. The Endoscopes Market analyzes the market segments such as Laparoscope, Arthroscope, Cystoscope, Urology Endoscope, Gynecology Endoscope, Neuroendoscope, Other Rigid Endoscopes. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming |
|
|
North American Flexible Endoscopes Market The North American Flexible Endoscopes Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $1.27 billion in 2013 and expected to be $1.91 billion by 2018, growing at a CAGR of 8.5%. The Endoscopes Market analyzes the market segments such as Colonoscope, Bronchoscope, Upper GI Endoscope, Laryngoscope, Pharyngoscope, Deudonoscope, NasoPharyngoscope, Rhinoscope, Other Flexible Endoscopes. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming |
